logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Figure TDI-1. Trend in estimated number of new clients entering treatment by primary drug used, from 2005 to 2010

Part (ii) Numbers of clients by primary drug

 
 
Primary drug200520062007200820092010
Related links:
Heroin510265587061035527534848946486
Cocaine338173505735897367103706935930
Cannabis418194529047086459485324559065
Other stimulants9746954610696962477619741
Other drugs113981266110022116151224211620
Not known / missing6705125304549814886914176
Statistical bulletin 2012
See also ‘General notes for interpreting data’ on the Explanatory notes and help page

Notes:

Missing data were interpolated by assigning for the respective country the value for most recent year available. Altogether, 1.4% of the data points and 3.7% of the number of clients were interpolated.

Countries included: Bulgaria, Czech Republic, Denmark, Germany, Ireland, Greece, Spain, France, Italy, Cyprus, Latvia, Lithuania, Hungary, Malta, Netherlands, Austria, Portugal, Romania, Slovakia, Slovenia, Finland, Sweden, United Kingdom and Turkey.

Sources:

Reitox national reports 2011

Primary drug 2005 2006 2007 2008 2009 2010
Heroin 51026 55870 61035 52753 48489 46486
Cocaine 33817 35057 35897 36710 37069 35930
Cannabis 41819 45290 47086 45948 53245 59065
Other stimulants 9746 9546 10696 9624 7761 9741
Other drugs 11398 12661 10022 11615 12242 11620
Not known / missing 6705 12530 4549 8148 8691 4176

tdifig1b

 

Page last updated: Monday, 09 July 2012